Overview
AFRISUNATE-120 is an injectable Artesunate combipack for the treatment of severe malaria. Each pack contains a 120 mg Artesunate vial, a 2 ml ampoule of Sodium Bicarbonate Injection BP 5% w/v to dissolve the powder, and a 10 ml ampoule of Sodium Chloride Injection BP 0.9% w/v for dilution. It can be given by intramuscular or intravenous injection.
Indications
Injectable Artesunate is widely used for:
- Initial treatment of severe malaria in adults and children
- Treatment of Plasmodium falciparum malaria when oral therapy is not possible
Prescription only medicine. To be administered by a qualified healthcare professional. Treatment is usually completed with a full course of oral artemisinin-based combination therapy.
Export Supply
AFRISUNATE-120 is available for export to distributors, importers and hospital suppliers in malaria-endemic regions. Every order includes:
- Manufactured at WHO-GMP certified partner plants in India
- Batch Certificate of Analysis (COA) with every shipment
- Export documentation: commercial invoice, packing list and certificate of origin
- Sea and air shipping to Africa, Southeast Asia, Latin America, CIS and the Middle East
